FDA Warning Letter — Amgen, Inc.

Case 739641 — FEI 2026154

The FDA took a Warning Letter action against Amgen, Inc. on Aug 12, 2026 (Thousand Oaks, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Amgen, Inc.
Date
Aug 12, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Thousand Oaks, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.